Press Release: Danimer Scientific Announces Third Quarter 2024 Results

Dow Jones
19 Nov 2024
       assets                                    (239)      1,816 
      Contract assets                            (759)     (1,244) 
      Other assets                                 76        (119) 
      Accounts payable                           (638)     (2,061) 
      Accrued liabilities                       1,588       1,893 
      Other long-term liabilities                 217         706 
      Unearned revenue and contract 
       liabilities                                (85)        438 
                                              -------    -------- 
         Net cash used in operating 
          activities                          (46,460)    (31,331) 
                                              -------    -------- 
Cash flows from investing activities: 
   Purchases of property, plant and 
    equipment and intangible assets            (7,486)    (25,722) 
   Proceeds from disposals of property, 
    plant and equipment                         1,167          18 
                                              -------    -------- 
         Net cash used in investing 
          activities                           (6,319)    (25,704) 
                                              -------    -------- 
Cash flows from financing activities: 
   Proceeds from issuance of warrants, net 
    of issuance costs                           8,888           - 
   Proceeds from issuance of common stock, 
    net of issuance costs                       4,517           - 
   Proceeds from long-term debt                20,716     130,000 
   Principal payments on long-term debt       (17,594)    (12,437) 
   Cash paid for debt issuance costs           (1,097)    (33,296) 
   Proceeds from employee stock purchase 
    plan                                          176         282 
   Employee taxes related to stock-based 
    compensation                                  (28)        (61) 
                                              -------    -------- 
      Net cash provided by financing 
       activities                              15,578      84,488 
                                              -------    -------- 
         Net (decrease) increase in cash 
          and cash equivalents and 
          restricted cash                     (37,201)     27,453 
                                              -------    -------- 
Cash and cash equivalents and restricted 
 cash-beginning of period                      73,504      64,401 
                                              -------    -------- 
Cash and cash equivalents and restricted 
 cash-end of period                          $ 36,303   $  91,854 
                                              =======    ======== 
 

Non-GAAP Financial Measures

This press release includes the non-GAAP financial measures "Adjusted EBITDA", "Adjusted gross profit" and "Adjusted gross margin". Danimer management views these metrics as a useful way to look at the performance of its operations between periods and to exclude decisions on capital investment and financing that might otherwise impact the review of profitability of the business based on present market conditions.

Adjusted EBITDA is defined as net income or loss plus net interest expense, income taxes, depreciation and amortization, as adjusted to add back certain charges or gains that Danimer may record each period such as remeasurement of warrants, stock-based compensation expense, as well as non-recurring charges such as (i) asset disposal gains or losses as well as other significant gains or losses such as debt extinguishments and impairment of goodwill; (ii) legal settlements; or (iii) other discrete non-recurring items. Danimer believes these items are not considered an indicator of ongoing performance. Adjusted EBITDA is not a measure of performance defined in accordance with GAAP. The measure is used as a supplement to GAAP results in evaluating certain aspects of Danimer's business, as described below.

Adjusted gross profit is defined as gross profit plus depreciation, stock-based compensation and other nonrecurring items.

Adjusted gross margin is defined as adjusted gross profit divided by total revenue.

Danimer believes that each of Adjusted EBITDA, Adjusted gross profit and Adjusted gross margin is useful to investors in evaluating the Company's performance because each measure considers the performance of the Company's operations, excluding decisions made with respect to capital investment, financing and other non-recurring charges as outlined in the preceding paragraph. Danimer believes these non-GAAP metrics offer additional financial information that, when coupled with the GAAP results and the reconciliation to GAAP results, provides a more complete understanding of its results of operations and the factors and trends affecting its business.

Adjusted EBITDA, Adjusted gross profit and Adjusted gross margin should not be considered as an alternative to net income or loss as an indicator of its performance or as alternatives to any other measure prescribed by GAAP as there are limitations to using such non-GAAP measures. Although Danimer believes that Adjusted EBITDA, Adjusted gross profit and Adjusted gross margin may enhance an evaluation of its operating performance based on recent revenue generation and product/overhead cost control because it excludes the impact of prior decisions made about capital investment, financing and other expenses, (i) other companies in Danimer's industry may define Adjusted EBITDA, Adjusted gross profit and Adjusted gross margin differently than Danimer does and, as a result, they may not be comparable to similarly titled measures used by other companies in its industry, and (ii) Adjusted EBITDA, Adjusted gross profit and Adjusted gross margin exclude certain financial information that some may consider important in evaluating Danimer's performance.

Danimer compensates for these limitations by providing disclosure of the differences between Adjusted EBITDA, Adjusted gross profit and Adjusted gross margin and GAAP results, including providing a reconciliation to GAAP results, to enable investors to perform their own analysis of Danimer's operating results. Because GAAP financial measures on a forward-looking basis are not accessible, and reconciling information is not available without unreasonable effort, reconciliations to GAAP financial measures are not provided for forward-looking non-GAAP measures. For the same reasons, the Company is unable to address the probable significance of the unavailable information, which could be material to future results.

 
                        Danimer Scientific, Inc. 
       Reconciliation of Adjusted EBITDA to Net Loss (Unaudited) 
 
                                    Three Months Ended September 30, 
                                ---------------------------------------- 
                                         2024                 2023 
                                ----------------------  ---------------- 
(in thousands) 
Net loss                           $      (21,839)      $   (40,159) 
   Interest, net                            9,631             8,584 
   Depreciation and 
    amortization                            7,376             7,253 
   (Gain) loss on loan 
    extinguishment                         (6,821)                - 
   Transaction and other 
    related                                 1,197                 - 
   Stock-based compensation                   744            14,324 
   Strategic reorganization 
    and related                               522               382 
   Loss (gain) on 
    remeasurement of warrants                 206              (132) 
   Litigation and other legal 
    related                                   101                28 
   Income taxes                                 2               468 
                                ----  -----------  ---   ----------  --- 
Adjusted EBITDA                    $       (8,881)      $    (9,252) 
                                ----  -----------        ---------- 
 
  Reconciliation of Adjusted Gross Profit to Gross Profit (Unaudited) 
 
                                    Three Months Ended September 30, 
                                ---------------------------------------- 
                                         2024                 2023 
                                ----------------------  ---------------- 
(in thousands) 
Total revenue                      $        8,630       $    10,948 
Cost of revenue                            15,945            18,685 
                                ----  -----------  ---   ----------  --- 
Gross profit                               (7,315)           (7,737) 
   Depreciation                             5,049             5,086 
   Stock-based compensation                     3                 2 
                                ----  -----------  ---   ----------  --- 
Adjusted gross profit              $       (2,263)      $    (2,649) 
                                ====  ===========        ========== 
 
Adjusted gross margin                       (26.2%)           (24.2%) 
                                ====  ===========        ========== 
 

View source version on businesswire.com: https://www.businesswire.com/news/home/20241119474813/en/

 
    CONTACT:    Investor Relations and Media 

Blake Chamblee

Phone: 770-337-6570

ir@danimer.com

 
 

(END) Dow Jones Newswires

November 19, 2024 08:30 ET (13:30 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10